Fragile X syndrome clinical trials: exploring parental decision-making.
Celeste S D'AmandaHolly L PeayAnne C WheelerErin TurbittBarbara B BieseckerPublished in: Journal of intellectual disability research : JIDR (2019)
Therapeutic optimism was high among those who elected participation. Parents may benefit from an explanation of the rationale behind chosen outcome variables and may be more interested in trials that target or measure as an exploratory outcome the symptoms they find most concerning. Our findings reinforce the need for future trials to reduce participant inconvenience. Our results contrast with what has previously been observed in parents of children with life-threatening conditions; parents of children with FXS may be more trial risk averse and find trial decisions to be harder. Parents of children with FXS considering trials may benefit from a decisional intervention aimed at deliberating motivations and barriers.